Fenfluramine Hydrochloride

CHEMBL2106217 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
267.7 g/mol
LogP
Phase
4

This medication contains fenfluramine, which acts on serotonin receptors in the brain to help reduce seizure frequency in certain rare epileptic conditions. Originally developed as an appetite suppressant, it has found important use in treating Dravet syndrome and other treatment-resistant epilepsies.

Peso Molecular

267,7200 g/mol

TPSA

12,00 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl

InChI

InChI=1S/C12H16F3N.ClH/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15;/h4-6,8-9,16H,3,7H2,1-2H3;1H

Molecular Formula

C12H17ClF3N

HBD / HBA

2 / 4

Ligações Rotacionáveis

4

Átomos Pesados

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This medication contains fenfluramine, which acts on serotonin receptors in the brain to help reduce seizure frequency in certain rare epileptic conditions. Originally developed as an appetite suppressant, it has found important use in treating Dravet syndrome and other treatment-resistant epilepsies.

Yes, Fenfluramine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2106217. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 91452. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.